INTCO Medical 2025 Annual Report: Steady Growth, Global Manufacturing, and Innovation

 Stable Financial Performance Supporting Long-Term Growth

In 2025, INTCO Medical achieved total revenue of RMB 9.926 billion, representing a year-on-year increase of 4.23%. Although net profit experienced a temporary decline due to external market conditions, the company maintained strong operational resilience.

Operating cash flow reached RMB 1.885 billion, increasing by 74.69% year-on-year, reflecting improved efficiency and strong cash generation. Net assets attributable to shareholders also grew steadily to RMB 18.254 billion, up 4.88%, providing a solid foundation for future expansion.

Large-Scale Manufacturing Strength Across Medical Products

INTCO’s global manufacturing scale remains a key competitive advantage, particularly in medical consumables.

The company’s disposable glove production capacity has reached 103 billion units annually, including:

• 70 billion nitrile gloves
• 33 billion PVC gloves

This large-scale production system ensures supply stability, cost efficiency, and the ability to support high-volume global demand—capabilities that also reinforce INTCO’s expansion into other healthcare product categories.

Expanding Presence in Rehabilitation and Mobility Solutions

Building on its manufacturing expertise, INTCO continues to strengthen its position in rehabilitation equipment.

The company’s annual wheelchair production capacity has reached 1.1 million units, including:

• Approximately 1 million manual wheelchairs
• Approximately 100,000 electric wheelchairs

This enables INTCO to meet diverse global mobility needs while supporting OEM and bulk procurement requirements for international clients.

Integrated Global Production and Supply Network

INTCO operates more than 10 R&D and manufacturing bases worldwide, forming a highly efficient global production system.

The Zhenjiang production base plays a key role in rehabilitation and mobility equipment manufacturing, while other facilities across China and Vietnam support medical consumables production.

In addition, global marketing centers in Shanghai, Hong Kong, the United States, Germany, Canada, Japan, and Malaysia ensure efficient distribution and localized service.

Innovation Driving Product Development and Competitiveness

Innovation remains at the core of INTCO’s strategy. In 2025, the company invested RMB 404 million in R&D, accounting for 4.07% of total revenue, and accumulated 298 patents.

New product developments include:

• Syntex™ synthetic latex gloves
• ShinyGuard™ food-grade nitrile gloves
• ECO & YK9070 manual wheelchairs
• MOVO-F foldable walker

This reflects INTCO’s ability to innovate across both high-volume consumables and rehabilitation products.

AI Integration Enhancing Efficiency and Quality

INTCO is actively embracing artificial intelligence to improve operational efficiency.

By building enterprise data platforms and deploying localized AI models, the company enhances production processes, quality control, and decision-making across its manufacturing systems, including both consumables and mobility equipment.

Global Market Expansion and Brand Growth

INTCO’s products are now sold in more than 150 countries and regions, serving over 15,000 global clients.

With a global marketing team of over 500 professionals and participation in 27 international exhibitions in 2025, the company continues to strengthen its global presence.

The brand value has reached RMB 19.618 billion, reflecting increasing international recognition.

Future Outlook: Advancing Global Healthcare Solutions

Looking ahead, INTCO Medical will continue to focus on globalization, innovation, and manufacturing efficiency.

By leveraging its scale advantages and expanding its product ecosystem, the company aims to build a more resilient and competitive global healthcare platform, while further strengthening its position in both medical consumables and rehabilitation markets.